These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8354178)

  • 1. Genetic toxicology: current status of methods of carcinogen identification.
    Tennant RW; Zeiger E
    Environ Health Perspect; 1993 Apr; 100():307-15. PubMed ID: 8354178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that toxic injury is not always associated with induction of chemical carcinogenesis.
    Tennant RW; Elwell MR; Spalding JW; Griesemer RA
    Mol Carcinog; 1991; 4(6):420-40. PubMed ID: 1793481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet?
    Benigni R
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):407-17. PubMed ID: 22360376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens.
    Tennant RW; Spalding J
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1095-100. PubMed ID: 8933059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of rodent carcinogenicity for 44 chemicals: results.
    Ashby J; Tennant RW
    Mutagenesis; 1994 Jan; 9(1):7-15. PubMed ID: 8208133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
    French J; Storer RD; Donehower LA
    Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents.
    Rosenkranz HS; Klopman G
    Environ Mol Mutagen; 1993; 21(2):193-206. PubMed ID: 8444146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard.
    Tennant RW
    Mutat Res; 1993 Mar; 286(1):111-8. PubMed ID: 7678907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemicals for evaluating the sensitivity and specificity of reduced/transgenic rodent cancer bioassay protocols.
    Ashby J; Paton D
    Mutat Res; 1995 Sep; 331(1):27-38. PubMed ID: 7666866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
    Mauthe RJ; Gibson DP; Bunch RT; Custer L
    Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tg.AC genetically altered mouse: assay working group overview of available data.
    Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF
    Toxicol Pathol; 2001; 29 Suppl():60-80. PubMed ID: 11695563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program. The DEREK Collaborative Group.
    Marchant CA
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1065-73. PubMed ID: 8933056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.